NYSEAMERICAN : YCBD
cbdMD, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.3827 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.29M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.29M |
| Enterprise Value | 4.38M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 18, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 11.21M |
| Shares Outstanding | 11.21M |
| Shares Change (YoY) | +382.43% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 15.20% |
| Float | 10.91M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| Forward PS | 0.16 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.50 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 28.33 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -40.33% |
| Return on Assets (ROA) | -15.75% |
| Return on Invested Capital (ROIC) | -20.74% |
| Return on Capital Employed (ROCE) | -28.84% |
| Weighted Average Cost of Capital (WACC) | 10.97% |
| Revenue Per Employee | $498,368 |
| Profits Per Employee | -$73,324 |
| Employee Count | 42 |
| Asset Turnover | 1.82 |
| Inventory Turnover | 2.67 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.25 |
| 52-Week Price Change | -59.72% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 44.57 |
| Average Volume (20 Days) | 86,882 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 546,032 |
| Short Previous Month | 511,113 |
| Short % of Shares Out | 4.87% |
| Short % of Float | 5.01% |
| Short Ratio (days to cover) | 0.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 20.93M |
| Gross Profit | 12.07M |
| Operating Income | -2.90M |
| Pretax Income | -2.89M |
| Net Income | -3.08M |
| EBITDA | -1.89M |
| EBIT | -2.90M |
| Loss Per Share | -$0.32 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.12M |
| Total Debt | 2.21M |
| Net Cash | -93,925 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 8.21M |
| Book Value Per Share | 0.74 |
| Working Capital | 4.62M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.22M |
| Capital Expenditures | -191,419 |
| Depreciation & Amortization | 1.02M |
| Net Borrowing | 61,990 |
| Free Cash Flow | -2.41M |
| FCF Per Share | -$0.22 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.68% |
| Operating Margin | -13.87% |
| Pretax Margin | -13.80% |
| Profit Margin | -13.80% |
| EBITDA Margin | -9.01% |
| EBIT Margin | -13.87% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -382.43% |
| Shareholder Yield | -382.43% |
| Earnings Yield | -82.51% |
| FCF Yield | -56.18% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -17.07 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |